The number of tumor infiltrating T-cell subsets in lymph nodes from patients with Hodgkin lymphoma is associated with the outcome after first line ABVD therapy.
about
Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin's lymphoma with an emphasis on targeted therapies and transplantation strategiesFollicular CD8+ T Cells: Origin, Function and Importance during HIV Infection.An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome.Glancing at the complex biology of T-cells through the microenvironment of Hodgkin lymphoma<sup/>.Autologous tumor cells/bacillus Calmette-Guérin/formalin-based novel breast cancer vaccine induces an immune antitumor response.
P2860
The number of tumor infiltrating T-cell subsets in lymph nodes from patients with Hodgkin lymphoma is associated with the outcome after first line ABVD therapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
The number of tumor infiltrati ...... after first line ABVD therapy.
@en
The number of tumor infiltrati ...... after first line ABVD therapy.
@nl
type
label
The number of tumor infiltrati ...... after first line ABVD therapy.
@en
The number of tumor infiltrati ...... after first line ABVD therapy.
@nl
prefLabel
The number of tumor infiltrati ...... after first line ABVD therapy.
@en
The number of tumor infiltrati ...... after first line ABVD therapy.
@nl
P2093
P2860
P50
P1433
P1476
The number of tumor infiltrati ...... after first line ABVD therapy.
@en
P2093
Abelardo Bárez
Alberto Orfão
Alejandro Martin
Esther Zato
Josefina Galende
Maria Belén Vidriales
Maria Dolores Caballero
Maria Jesús Peñarrubia
Noemí Puig
Sara Alonso-Álvarez
P2860
P304
P356
10.1080/10428194.2016.1239263
P577
2016-10-12T00:00:00Z